Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Treatment of bladder cancer with Bi-213-anti-EGFR-MAb - A pilot study

Klemens Scheidhauer, Christof Seidl, Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis, Michael Autenrieth, Florian Kurtz, Markus Essler, Markus Schwaiger and Reingard Senekowitsch-Schmidtke
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 639;
Klemens Scheidhauer
1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christof Seidl
1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Morgenstern
2EC, JRC, Inst. Transuranium Elements, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Bruchertseifer
2EC, JRC, Inst. Transuranium Elements, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Apostolidis
2EC, JRC, Inst. Transuranium Elements, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Autenrieth
3Dept. of Urology, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Kurtz
3Dept. of Urology, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Essler
1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reingard Senekowitsch-Schmidtke
1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 639

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Klemens Scheidhauer1,
  2. Christof Seidl1,
  3. Alfred Morgenstern2,
  4. Frank Bruchertseifer2,
  5. Christos Apostolidis2,
  6. Michael Autenrieth3,
  7. Florian Kurtz3,
  8. Markus Essler1,
  9. Markus Schwaiger1 and
  10. Reingard Senekowitsch-Schmidtke1
  1. 1Dept. of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
  2. 2EC, JRC, Inst. Transuranium Elements, Karlsruhe, Germany
  3. 3Dept. of Urology, Technische Universitaet Muenchen, Munich, Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014600
Dec 2014100
Feb 20153400
Mar 2015500
Apr 2015100
May 2015200
Jun 2015500
Jul 2015500
Aug 20151500
Sep 20151200
Oct 2015400
Nov 2015400
Dec 2015400
Jan 2016400
Feb 2016300
Mar 2016100
Apr 2016100
Jun 20161200
Jul 2016300
Sep 20163500
Oct 2016700
Nov 2016200
Dec 2016800
Jan 20172700
Feb 2017500
Mar 2017400
Apr 2017600
May 20171200
Jun 20171000
Jul 2017300
Aug 2017600
Sep 20171000
Oct 20171300
Nov 20171200
Dec 2017600
Jan 2018200
Feb 20185000
Mar 2018500
Apr 20181800
May 2018400
Jun 2018200
Sep 20181500
Oct 2018600
Nov 20181000
Dec 2018300
Jan 2019900
Feb 2019200
Mar 2019500
Apr 2019300
May 2019100
Jun 2019400
Jul 2019300
Aug 2019800
Sep 2019500
Oct 2019300
Nov 2019300
Dec 2019100
Jan 2020800
Feb 20201500
Mar 20201900
Apr 20201000
May 2020300
Jun 2020300
Jul 2020300
Aug 2020900
Sep 20203500
Oct 20202100
Nov 20202300
Dec 20201500
Jan 2021500
Feb 20211900
Mar 20211300
Apr 20211000
May 20212700
Jun 20211500
Jul 20217500
Aug 20215100
Sep 20211600
Oct 20211800
Nov 20217500
Dec 20215100
Jan 20226800
Feb 20221900
Mar 20222800
Apr 20223100
May 20222400
Jun 2022500
Jul 20221200
Aug 2022500
Sep 2022800
Oct 20221400
Nov 2022500
Dec 2022800
Jan 20231100
Feb 2023400
Mar 20231000
Apr 2023200
May 20231000
Jun 2023600
Jul 2023400
Aug 2023700
Sep 20231500
Oct 2023800
Nov 2023300
Dec 2023500
Jan 2024800
Feb 2024400
Mar 2024200
Apr 2024600
May 2024600
Jun 2024600
Jul 20241200
Aug 2024700
Sep 20241100
Oct 2024700
Nov 2024600
Dec 2024400
Jan 2025200
Feb 2025700
Mar 2025700
Apr 20251300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment of bladder cancer with Bi-213-anti-EGFR-MAb - A pilot study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Treatment of bladder cancer with Bi-213-anti-EGFR-MAb - A pilot study
Klemens Scheidhauer, Christof Seidl, Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis, Michael Autenrieth, Florian Kurtz, Markus Essler, Markus Schwaiger, Reingard Senekowitsch-Schmidtke
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 639;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment of bladder cancer with Bi-213-anti-EGFR-MAb - A pilot study
Klemens Scheidhauer, Christof Seidl, Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis, Michael Autenrieth, Florian Kurtz, Markus Essler, Markus Schwaiger, Reingard Senekowitsch-Schmidtke
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 639;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Radiopeptide Therapy using Lu-177 3BP-227 in a Patient with Pancreatic Adenocarcinoma
  • Radiolabeing of Tyr-cNGQGEQc with iodine-131 and its biodistribution and radioherapy in nude mice bearing lung adenocarcinoma
  • Analysis on correlation of Tg with lesions counts ratio of 131I-WBS in DTC patients
Show more Oncology: Basic, Translational & Therapy

Radiopharmaceutical Therapy: Radioimmunotherapy

  • Dose escalation of first in human alpha radioimmunotherapy with 212Pb-TCMC-trastuzumab
  • Strong anti-tumor effect of 177Lu-tetraxetan-tetulomab in nude mice with Ramos xenografts
Show more Radiopharmaceutical Therapy: Radioimmunotherapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire